TCRT Stock Analysis: Buy, Sell, or Hold?
TCRT - Alaunos Therapeutics, Inc. Common Stock
$1.97
-0.02 (-1.01%)
▼
5d:
-24.81%
30d:
-25.1%
90d:
-43.23%
WAIT
LOW Confidence
Analysis Updated: Jun 10, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When TCRT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TCRT is down 24.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: TCRT is down 24.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: TCRT is currently trading at $1.97, which is considered oversold relative to its 30-day fair value range of $2.27 to $2.77.
Technical Outlook: Technically, TCRT is in a downtrend. The price is currently testing key support at $1.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $1.75. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TCRT is in a downtrend. The price is currently testing key support at $1.96. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $1.75. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.27 -
$2.77
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 12.1% above Wall St target ($1.75)
- WARNING: Recommendation downgraded due to -24.8% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$2.27 -
$2.77
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.96
Resistance Level
$3.09
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.48
Wall Street Target
$1.75
(-12.1%)
Revenue Growth (YoY)
-25.0%
Share & Embed Analysis
Last updated: June 10, 2026 4:01 PM ET
Data refreshes hourly during market hours. Next update: 5:01 PM
Data refreshes hourly during market hours. Next update: 5:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TCRT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 63 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 53 HOLD |
